Total Funding
47
70
Total FundingPost-IPO Debt raised
Growth Score
-30 pts
Heat Score
20 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
7606
Viridian Therapeutics is a biotechnology company that offers treatments for patients suffering from diseases.
- Paul Rubin: Executive Vice-President of Research and Development
- Carrie Melvin: Chief Operating Officer
About the Company
Viridian Therapeutics provides treatments for patients with diseases that are underserved by therapies. They develops product candidates to treat patients who suffer from thyroid eye disease, a debilitating orphan disease, and early-stage programs focused on targets and indications.
